$BYON
BEYOND, INC.

2023 Q2 Form 10-Q Financial Statement

#000113071323000032 Filed on May 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $422.2M $381.1M $404.9M
YoY Change -20.05% -28.9% -33.91%
Cost Of Revenue $327.8M $291.4M $315.3M
YoY Change -19.45% -29.06% -33.45%
Gross Profit $94.37M $89.71M $89.56M
YoY Change -22.07% -28.35% -35.5%
Gross Profit Margin 22.35% 23.54% 22.12%
Selling, General & Admin $69.89M $67.53M $64.20M
YoY Change -11.55% -15.34% -27.71%
% of Gross Profit 74.06% 75.27% 71.69%
Research & Development $24.42M $25.84M $24.91M
YoY Change -11.51% -13.25% -10.4%
% of Gross Profit 25.88% 28.81% 27.81%
Depreciation & Amortization $4.516M $5.985M $4.226M
YoY Change 12.06% 38.96% -1.72%
% of Gross Profit 4.79% 6.67% 4.72%
Operating Expenses $98.62M $98.08M $92.20M
YoY Change -9.99% -13.02% -22.99%
Operating Profit -$4.249M -$8.364M -$2.647M
YoY Change -136.81% -167.16% -113.84%
Interest Expense $3.059M $2.559M $1.999M
YoY Change 2560.0% -2147.2% -2099.0%
% of Operating Profit
Other Income/Expense, Net -$80.67M -$7.389M -$15.45M
YoY Change 3972.34% 6381.58% -223.51%
Pretax Income -$81.86M -$13.19M -$16.10M
YoY Change -946.04% -208.01% -151.1%
Income Tax -$8.370M -$2.887M -$584.0K
% Of Pretax Income
Net Earnings -$73.49M -$10.31M -$15.51M
YoY Change -1128.31% -201.82% -147.09%
Net Earnings / Revenue -17.41% -2.7% -3.83%
Basic Earnings Per Share -$1.63 -$0.23 -$0.34
Diluted Earnings Per Share -$1.63 -$0.23 -$0.34
COMMON SHARES
Basic Shares Outstanding 45.20M shares 45.03M shares 45.74M shares
Diluted Shares Outstanding 45.20M shares 45.07M shares 45.42M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $342.9M $374.7M $371.3M
YoY Change -22.53% -24.03% -26.23%
Cash & Equivalents $342.9M $374.7M $371.3M
Short-Term Investments
Other Short-Term Assets $20.55M $18.23M $5.467M
YoY Change 0.67% -14.72% 7.81%
Inventory $6.313M $6.238M $6.526M
Prepaid Expenses
Receivables $19.12M $22.07M $17.69M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $388.9M $421.2M $414.5M
YoY Change -20.92% -22.54% -24.88%
LONG-TERM ASSETS
Property, Plant & Equipment $114.9M $107.1M $109.9M
YoY Change 6.38% -1.28% 0.39%
Goodwill $6.160M $6.160M $6.200M
YoY Change 0.0% 0.0% 0.65%
Intangibles $25.58M $9.000K
YoY Change
Long-Term Investments $208.5M $206.3M $213.5M
YoY Change -40.47% -41.47% -37.67%
Other Assets $66.52M $12.54M $2.755M
YoY Change 2284.19% 339.69% -14.86%
Total Long-Term Assets $421.7M $466.1M $464.0M
YoY Change -18.15% -10.47% -9.75%
TOTAL ASSETS
Total Short-Term Assets $388.9M $421.2M $414.5M
Total Long-Term Assets $421.7M $466.1M $464.0M
Total Assets $810.6M $887.4M $878.5M
YoY Change -19.5% -16.63% -17.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $86.02M $83.62M $75.13M
YoY Change -10.62% -21.39% -26.55%
Accrued Expenses $65.71M $68.59M $63.61M
YoY Change -28.41% -36.43% -37.57%
Deferred Revenue $44.48M
YoY Change -25.1%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $2.900M $3.500M
YoY Change -41.18% -14.71% 6.06%
Total Short-Term Liabilities $197.1M $206.1M $191.1M
YoY Change -22.28% -27.57% -29.81%
LONG-TERM LIABILITIES
Long-Term Debt $34.22M $34.21M $34.48M
YoY Change -5.6% -7.84% -9.27%
Other Long-Term Liabilities $6.032M $3.576M $3.476M
YoY Change 92.84% -0.31% 5.24%
Total Long-Term Liabilities $40.25M $3.576M $3.476M
YoY Change 1186.8% -0.31% 5.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $197.1M $206.1M $191.1M
Total Long-Term Liabilities $40.25M $3.576M $3.476M
Total Liabilities $237.4M $246.9M $232.7M
YoY Change -20.4% -25.6% -27.63%
SHAREHOLDERS EQUITY
Retained Earnings -$257.6M -$184.1M -$173.8M
YoY Change 112.35% 45.6% 27.26%
Common Stock $5.000K $5.000K $5.000K
YoY Change 25.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $162.5M
YoY Change 105.66%
Treasury Stock Shares 6.151M shares
Shareholders Equity $573.2M $640.5M $645.8M
YoY Change
Total Liabilities & Shareholders Equity $810.6M $887.4M $878.5M
YoY Change -19.5% -16.63% -17.58%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$73.49M -$10.31M -$15.51M
YoY Change -1128.31% -201.82% -147.09%
Depreciation, Depletion And Amortization $4.516M $5.985M $4.226M
YoY Change 12.06% 38.96% -1.72%
Cash From Operating Activities -$1.235M $20.01M -$30.13M
YoY Change -89.14% -39.73% 1334.81%
INVESTING ACTIVITIES
Capital Expenditures $29.62M $5.256M $5.175M
YoY Change -1040.44% 61.43% -232.69%
Acquisitions
YoY Change
Other Investing Activities $20.00K -$425.0K $145.0K
YoY Change -108.93% -251.25% -136.25%
Cash From Investing Activities -$29.60M -$14.83M -$5.030M
YoY Change 777.42% 7.51% 16.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.013M -$1.705M -21.12M
YoY Change -97.18% -94.18% 712.15%
NET CHANGE
Cash From Operating Activities -1.235M $20.01M -30.13M
Cash From Investing Activities -29.60M -$14.83M -5.030M
Cash From Financing Activities -1.013M -$1.705M -21.12M
Net Change In Cash -31.85M $3.471M -56.28M
YoY Change -37.16% -135.1% 525.3%
FREE CASH FLOW
Cash From Operating Activities -$1.235M $20.01M -$30.13M
Capital Expenditures $29.62M $5.256M $5.175M
Free Cash Flow -$30.86M $14.75M -$35.31M
YoY Change 275.37% -50.73% -2061.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001130713
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-49799
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
OVERSTOCK.COM, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0634302
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
799 West Coliseum Way
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Midvale
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84047
CY2023Q1 dei City Area Code
CityAreaCode
801
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
947-3100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
OSTK
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45199036 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
374711000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
371263000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
217000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
194000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3127000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3223000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22071000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17693000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
6238000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
6526000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18012000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18833000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
421249000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
414509000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
107064000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109906000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
44888000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
41439000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
6160000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
6160000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
82811000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
82823000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
289124000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
296317000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6364000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7460000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12540000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2755000 usd
CY2023Q1 us-gaap Assets
Assets
887389000 usd
CY2022Q4 us-gaap Assets
Assets
878546000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
83621000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
75130000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68593000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63614000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
47123000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
44480000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3872000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4410000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2910000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3508000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
206119000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
191142000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
34207000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
34476000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2982000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3626000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3576000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3476000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
246884000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
232720000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51438000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51102000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45191000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44951000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
989634000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
982718000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-184136000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173829000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-518000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-522000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6247000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6151000 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
164480000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
162546000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
640505000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
645826000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
887389000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
878546000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
381140000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
536037000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
291427000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
410825000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
89713000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
125212000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
47048000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
58513000 usd
CY2023Q1 ostk Technology Expense
TechnologyExpense
30546000 usd
CY2022Q1 ostk Technology Expense
TechnologyExpense
32989000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20483000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21256000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
98077000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
112758000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8364000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12454000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2559000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-125000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7389000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-114000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13194000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12215000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2887000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2092000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-10307000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10123000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45067000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43052000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45067000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43282000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-10307000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10123000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
4000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
4000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10303000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10127000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
640505000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
732610000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-10307000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10123000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5985000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4307000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1266000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1319000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5795000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4639000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3449000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-959000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-7181000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-299000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-102000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-123000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4378000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2559000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-288000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
282000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1109000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1604000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
369000 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
307000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10220000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4339000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5377000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7886000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2643000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2034000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1352000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1329000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
100000 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
284000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20007000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33193000 usd
CY2023Q1 ostk Disbursement For Notes Receivable
DisbursementForNotesReceivable
10000000 usd
CY2022Q1 ostk Disbursement For Notes Receivable
DisbursementForNotesReceivable
0 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
11420000 usd
CY2023Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 usd
CY2022Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-1162000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5256000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3256000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-425000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
281000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14831000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13795000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
25165000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1934000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3267000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
229000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-854000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1705000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29286000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3471000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9888000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
371457000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
503366000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
374928000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493478000 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
458000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent liabilities in our consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, receivables valuation, revenue recognition, Club O and gift card breakage, sales returns, inventory valuation, depreciable lives, equity and debt securities valuation, income taxes, stock-based compensation, performance-based compensation, self-funded health insurance liabilities, and contingencies. Although these estimates are based on our best knowledge of current events and actions that we may undertake in the future, our accounting of these estimates may change from period to period. To the extent there are differences between these estimates and actual results, our consolidated financial statements may be materially affected.</span></div>
CY2023Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
30300000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
255209000 usd
CY2023Q1 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
82811000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10107000 usd
CY2023Q1 us-gaap Trading Securities
TradingSecurities
443000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
348570000 usd
CY2023Q1 us-gaap Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent
DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent
458000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
252650000 usd
CY2022Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
82823000 usd
CY2022Q4 us-gaap Trading Securities
TradingSecurities
399000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
335872000 usd
CY2022Q4 us-gaap Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent
DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent
396000 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
396000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
355893000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
354676000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
248829000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
244770000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
107064000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109906000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
5980000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
4286000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
206313000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
213494000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
289124000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
296317000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
289100000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7181000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1464000 usd
CY2023Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 usd
CY2022Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
1165000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1406000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1509000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
364000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
498000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1492000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1550000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M1D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y14D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3487000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2880000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
689000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
250000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
83000 usd
CY2023Q1 ostk Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7389000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
535000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
6854000 usd
CY2023Q1 ostk Common Stock Number Of Votes
CommonStockNumberOfVotes
1 vote
CY2023Q1 ostk Proceeds From Issuance Of Common Stock Included In Accounts Receivable
ProceedsFromIssuanceOfCommonStockIncludedInAccountsReceivable
0 usd
CY2022Q1 ostk Proceeds From Issuance Of Common Stock Included In Accounts Receivable
ProceedsFromIssuanceOfCommonStockIncludedInAccountsReceivable
0 usd
CY2023Q1 ostk Common Stock Aggregate Offering Price
CommonStockAggregateOfferingPrice
150000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
19900000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
32993000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5795000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4639000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Employee Stock Ownership Plan
StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
68011 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Employee Stock Ownership Plan
StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
41918 shares
CY2023Q1 ostk Stock Issued During Period Employee Stock Ownership Plan Average Price Per Share
StockIssuedDuringPeriodEmployeeStockOwnershipPlanAveragePricePerShare
16.46
CY2022Q1 ostk Stock Issued During Period Employee Stock Ownership Plan Average Price Per Share
StockIssuedDuringPeriodEmployeeStockOwnershipPlanAveragePricePerShare
48.37
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
59387000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-47900000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44480000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25052000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-22409000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47123000 usd
CY2023Q1 ostk Gift Card And Club O Rewards Breakage
GiftCardAndClubORewardsBreakage
849000 usd
CY2022Q1 ostk Gift Card And Club O Rewards Breakage
GiftCardAndClubORewardsBreakage
1100000 usd
CY2021Q4 ostk Sales Return Reserve For Sales Returns Current
SalesReturnReserveForSalesReturnsCurrent
13923000 usd
CY2022 ostk Sales Returns Additions To Reserve For Sales Returns
SalesReturnsAdditionsToReserveForSalesReturns
161492000 usd
CY2022 ostk Deductions From Sales Returns Current
DeductionsFromSalesReturnsCurrent
165193000 usd
CY2022Q4 ostk Sales Return Reserve For Sales Returns Current
SalesReturnReserveForSalesReturnsCurrent
10222000 usd
CY2023Q1 ostk Sales Returns Additions To Reserve For Sales Returns
SalesReturnsAdditionsToReserveForSalesReturns
30155000 usd
CY2023Q1 ostk Deductions From Sales Returns Current
DeductionsFromSalesReturnsCurrent
29961000 usd
CY2023Q1 ostk Sales Return Reserve For Sales Returns Current
SalesReturnReserveForSalesReturnsCurrent
10416000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10307000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
10123000 usd
CY2023Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 usd
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
182000 usd
CY2023Q1 ostk Net Income Loss Available To Common Stockholders Before Undistributed Earnings Loss Allocated To Participating Securities Basic
NetIncomeLossAvailableToCommonStockholdersBeforeUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-10307000 usd
CY2022Q1 ostk Net Income Loss Available To Common Stockholders Before Undistributed Earnings Loss Allocated To Participating Securities Basic
NetIncomeLossAvailableToCommonStockholdersBeforeUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
9941000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
952000 usd
CY2023Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-10307000 usd
CY2022Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
8989000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45067000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43052000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
230000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45067000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43282000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
19900000 usd

Files In Submission

Name View Source Status
ostk-20230331_def.xml Edgar Link unprocessable
ostk-20230331_pre.xml Edgar Link unprocessable
0001130713-23-000032-index-headers.html Edgar Link pending
0001130713-23-000032-index.html Edgar Link pending
0001130713-23-000032.txt Edgar Link pending
0001130713-23-000032-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ostk-20230331.htm Edgar Link pending
ostk-20230331.xsd Edgar Link pending
ostk-20230331xexx311.htm Edgar Link pending
ostk-20230331xexx312.htm Edgar Link pending
ostk-20230331xexx321.htm Edgar Link pending
ostk-20230331xexx322.htm Edgar Link pending
ostk-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
ostk-20230331_lab.xml Edgar Link unprocessable
ostk-20230331_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending